SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0000921895-16-003835
Filing Date
2016-03-28
Accepted
2016-03-25 17:38:10
Documents
3

Document Format Files

Seq Description Document Type Size
1 THE SCHEDULE 13D sc13d09013007_03252016.htm SC 13D 322384
2 JOINT FILING AND SOLICITATION AGREEMENT ex991to13d09013007_03252016.htm EX-99.1 33756
3 POWERS OF ATTORNEY ex992to13d09013007_03252016.htm EX-99.2 18279
  Complete submission text file 0000921895-16-003835.txt   376066
Mailing Address 349 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 349 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 650-246-6400
Diadexus, Inc. (Subject) CIK: 0001036968 (see all company filings)

IRS No.: 943236309 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-56525 | Film No.: 161530224
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2687 CALIFORNIA STREET SAN FRANCISCO CA 94115
Business Address 2687 CALIFORNIA STREET SAN FRANCISCO CA 94115 (607) 216-8905
Meson Capital Partners LLC (Filed by) CIK: 0001535880 (see all company filings)

IRS No.: 272906428 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D